Fusion Finance Limited
Key Event and Approval
The Nomination and Remuneration Committee of the Board of Directors of Fusion Finance Limited approved the grant of Employee Stock Options (ESOPs) in its meeting held on Monday, August 10, 2026.
Details of the Grant
- Number of Options Granted: 10,000 (Ten Thousand) stock options.
- Scheme: Fusion Employee Stock Option Plan 2023 (ESOP 2023).
- Recipients: Eligible employees of the Company.
- Exercise Price: ₹204.99 per stock option. This price is based on the closing price of the company's shares on the National Stock Exchange of India Limited (NSE) on August 07, 2026.
- Compliance: The grant is made in compliance with the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
Vesting and Exercise Schedule
- Vesting Period: The options shall vest no earlier than 1 year from the Grant Date (August 10, 2026). The maximum vesting period will be as prescribed in the ESOP 2023 plan document.
- Exercise Period: The options may be exercised within a window of 8 (Eight) years from the date they vest.
Other Details
As this is a new grant, details pertaining to options exercised, money realized, shares issued, options lapsed, term variations, and diluted EPS are marked as 'Not Applicable' in the annexure. The disclosure also references SEBI Master Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026.
Financial and Capital Impact
The immediate financial impact of the grant is not quantified in the disclosure. The potential future capital structure impact, upon exercise of all options, would be an increase in the paid-up share capital by 10,000 shares. The specific dilution effect is not calculated or disclosed.
Additional Information
A copy of the disclosure letter is available on the company's website at www.fusionfin.com. The communication was signed by Vikrant Sadana, Company Secretary and Compliance Officer.